Peptide activity in cell-based experiments depends critically on cellular uptake, because most peptides are too large and hydrophilic to diffuse freely across the lipid bilayer. Research has identified multiple uptake routes, including endocytic internalization, transporter-mediated uptake, cell-penetrating peptide (CPP) mechanisms, and receptor-mediated endocytosis. Understanding these mechanisms is essential for designing experiments that distinguish where a peptide acts: at the cell surface, in the cytoplasm, or inside an organelle.
Endocytosis Pathways for Peptide Internalization
Endocytosis encompasses multiple pathways including clathrin-mediated endocytosis (CME), caveolin-mediated endocytosis (CvME), and macropinocytosis. Many peptides undergo non-specific fluid-phase endocytosis, entering cells within vesicles. When cationic CPPs such as the Tat 48-60 fragment and nona-arginine were re-examined in live, unfixed cells, they showed a characteristic endosomal distribution, and their uptake was inhibited at low temperature and by ATP depletion, consistent with endocytosis (Richard et al., 2003). Following endocytosis, peptides must escape endosomal compartments (the “endosomal escape problem”) to reach cytoplasmic targets, which some sequences accomplish through membrane-disrupting or endosome-destabilizing properties.
A Short History of Cell-Penetrating Peptides
The CPP field began in 1988, when two groups independently reported that the HIV-1 Tat protein could be taken up by cells from the culture medium (Frankel & Pabo, 1988; Green & Loewenstein, 1988). In 1994, the third helix of the Antennapedia homeodomain, later known as penetratin, was shown to translocate through biological membranes (Derossi et al., 1994). Later comparisons showed that polyarginine entered cells more efficiently than other polycationic homopolymers (Mitchell et al., 2000). These findings established arginine-rich sequences as the prototype CPP motif.
Cell-Penetrating Peptide (CPP) Mechanisms
Cell-penetrating peptides are short sequences (typically 4-30 amino acids) with high positive charge density that cross cell membranes through energy-dependent and, under some conditions, energy-independent mechanisms. Cationic CPPs interact with negatively charged membrane proteoglycans and phospholipids, facilitating direct translocation or triggering endocytosis (Deshayes et al., 2005). The balance between these routes depends on peptide concentration, cargo, cell type, and temperature, so uptake results from one cell line do not automatically transfer to another.
Mitochondria-Targeted Peptides: The SS-Peptide Example
Szeto–Schiller (SS) peptides are a distinct class of small aromatic-cationic tetrapeptides. SS-31 (D-Arg-Dmt-Lys-Phe-NH2) contains a D-arginine at the N-terminus and a 2′,6′-dimethyltyrosine residue. Members of this family were reported to be cell-permeable and to concentrate roughly 1000-fold in the inner mitochondrial membrane (Zhao et al., 2004). For the related tetrapeptide [Dmt1]DALDA, uptake into Caco-2 cells was detected within 5 minutes and was temperature-independent, and the dipeptide transporter PEPT1 was not involved (Zhao et al., 2003). A practical caveat came from the same group: attaching bulky fluorescent dyes to these tetrapeptides altered their intracellular targeting (Szeto et al., 2005). Researchers working with SS-31 50mg can find related background in our article on mitochondrial function and energy metabolism.
Transporter-Mediated Uptake
Di- and tripeptides can be carried into cells by proton-coupled oligopeptide transporters such as PepT1. The anti-inflammatory tripeptide KPV (Lys-Pro-Val) is one studied example: in intestinal epithelial and immune cell lines, KPV acted via PepT1, and nanomolar concentrations inhibited NF-κB and MAP kinase inflammatory signaling (Dalmasso et al., 2008). Transporter-dependent uptake is usually confirmed by competition with a known substrate and by testing cells with and without transporter expression. KPV 10mg is available for this kind of laboratory work.
Receptor-Mediated Uptake and Signaling
Many peptides act on cell-surface receptors, such as G-protein coupled receptors, without crossing the membrane, and some ligand–receptor complexes are internalized. In endothelial cell studies, for example, BPC-157 was associated with increased internalization of VEGFR2, an effect blocked by the endocytosis inhibitor dynasore, along with activation of VEGFR2-Akt-eNOS signaling (Hsieh et al., 2017).
How Uptake Is Measured in the Lab
Live-cell imaging. Fluorescence microscopy on live, unfixed cells avoids the artifactual uptake that fixation can cause (Richard et al., 2003).
Flow cytometry with a trypsin step. Membrane-bound peptide must be stripped before analysis, or surface binding will be counted as uptake.
Energy and pathway controls. Incubation at 4 °C, ATP depletion, and inhibitors such as dynasore help separate endocytosis from direct translocation.
Label choice. Radiolabeled or minimally modified peptides are preferred where possible, because large fluorophores can change where a peptide goes (Szeto et al., 2005).
Peptide stability also affects uptake readouts, since degraded fragments may be taken up differently; see our article on peptide stability and degradation.
Key Findings from the Literature
CPP uptake is largely endocytic in live cells. Earlier reports of non-endocytic uptake were partly explained by fixation and flow-cytometry artifacts (Richard et al., 2003).
Some peptides target organelles. SS peptides concentrated about 1000-fold in the inner mitochondrial membrane (Zhao et al., 2004).
Frequently Asked Questions
Do all peptides need to enter cells to be active?
No. Many peptides act on cell-surface receptors and trigger signaling without crossing the membrane. Uptake matters most when the target is intracellular.
Why do uptake results differ between studies?
Cell type, peptide concentration, temperature, labeling strategy, and whether cells were fixed all change the result. Fixation and missing trypsin washes were shown to inflate apparent uptake.
How should uptake experiments be controlled?
Common controls include low-temperature incubation, ATP depletion, pathway inhibitors, scrambled or non-penetrating control peptides, and live-cell imaging.
All BioSim peptides are supplied for laboratory research use only. They are not for human or veterinary use.
References
Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1), 166-78. PMID: 18061177 · DOI: 10.1053/j.gastro.2007.10.026
Derossi D, Joliot AH, Chassaing G, et al. (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. The Journal of biological chemistry, 269(14), 10444-50. PMID: 8144628
Deshayes S, Morris MC, Divita G, et al. (2005). Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cellular and molecular life sciences : CMLS, 62(16), 1839-49. PMID: 15968462 · DOI: 10.1007/s00018-005-5109-0
Frankel AD, Pabo CO (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 55(6), 1189-93. PMID: 2849510 · DOI: 10.1016/0092-8674(88)90263-2
Green M, Loewenstein PM (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 55(6), 1179-88. PMID: 2849509 · DOI: 10.1016/0092-8674(88)90262-0
Hsieh MJ, Liu HT, Wang CN, et al. (2017). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of molecular medicine (Berlin, Germany), 95(3), 323-333. PMID: 27847966 · DOI: 10.1007/s00109-016-1488-y
Mitchell DJ, Kim DT, Steinman L, et al. (2000). Polyarginine enters cells more efficiently than other polycationic homopolymers. The journal of peptide research : official journal of the American Peptide Society, 56(5), 318-25. PMID: 11095185 · DOI: 10.1034/j.1399-3011.2000.00723.x
Richard JP, Melikov K, Vives E, et al. (2003). Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. The Journal of biological chemistry, 278(1), 585-90. PMID: 12411431 · DOI: 10.1074/jbc.M209548200
Szeto HH, Schiller PW, Zhao K, et al. (2005). Fluorescent dyes alter intracellular targeting and function of cell-penetrating tetrapeptides. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 19(1), 118-20. PMID: 15489247 · DOI: 10.1096/fj.04-1982fje
Zhao K, Luo G, Zhao GM, et al. (2003). Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. The Journal of pharmacology and experimental therapeutics, 304(1), 425-32. PMID: 12490619 · DOI: 10.1124/jpet.102.040147
Zhao K, Zhao GM, Wu D, et al. (2004). Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. The Journal of biological chemistry, 279(33), 34682-90. PMID: 15178689 · DOI: 10.1074/jbc.M402999200
Related Products: Products discussed in this article: SS-31 50mg, BPC-157 10mg. Our research peptides are 99%+ purity and third-party tested; available certificates of analysis are published on our COA page. For laboratory research use only.
Related Research: Mitochondrial Function and Energy Metabolism: Peptides for Cellular Bioenergetics Research | Peptide Receptor Signaling: How Research Peptides Activate Cellular Pathways
